However, there is some evidence that point mutations may contribute to hypercalciuria, as heterozygous mice with the ENU-induced TRPV5 p.(Ser682Pro) variant have hypercalciuria and hyperphosphaturia, similar to the family described with the p.(Val598Met) variant. This evidence concerns the gene TRPV5 and Hypercalciuria.